ЭКСПЕРИМЕНТАЛЬНЫЕ КОРЕВЫЕ ВАКЦИНЫ КАК ИНСТРУМЕНТ ИССЛЕДОВАНИЯ ВАКЦИНАЛЬНОГО ПРОЦЕССА
https://doi.org/10.15789/1563-0625-2007-1-7-14
Аннотация
Об авторе
В. А. Ляшенко
ГУ НИИ вакцин и сывороток имени И.И. Мечникова РАМН, Москва
Россия
Россия
Лаборатория детских вирусных инфекций отдела вирусологии
115088, Москва, ул. 1-я Дубровская, д. 15. Тел.: (495) 674-01-99
Список литературы
1. Александер С.К., Ляшенко В.А., Юминова Н.В., Михайлова А.А. Исследование иммунизирующих свойств живых вакцин против кори и эпидемического паротита на некоторых лабораторных животных // Эпидемиология и вакцинопрофилактика. - 2005. - № 5 (24). - С. 19-23.
2. Белецкая Р.Г., Калюжная М.В., Ляшенко В.А., Ефремов М.А., Михайлова А.А. Миелопептид-2 - эндогенный иммуномодулятор, корригирующий функции поврежденных Т-лимфоцитов // Аллергия, астма и клиническая иммунология. - 2003. - Т., № 9. - С. 63-67.
3. Ляшенко В.А., Юминова Н.В., Краснова В.П. Особенности иммунного ответа взрослых добровольцев на интраназальную коревую вакцинацию // Иммунология. - 1993. - № 5. - С. 46-50.
4. Ляшенко В.А. Коревая иммунодепрессия в условиях инфекции и вакцинации // Иммунология. - 1996. - № 1. - С. 10-12.
5. Ляшенко В.А., Юминова Н.В., Краснова В.П. Неинъекционные методы использования живой коревой вакцины // Вопр. вирусологии. - 1996. - № 2. - С. 84-86.
6. Ляшенко В.А., Лавров В.Ф., Юминова Н.В., Ковалева Л.Г. Иммунодепрессивное действие вируса кори in vitro // Вопр. вирусологии. - 1999. - № 1. - С. 39-41.
7. Ляшенко В.А., Юминова Н.В., Краснова В.П., Свирина В.С. Интраназальная ревакцинация детей живой коревой вакциной. Развитие местного иммунитета // Вопр. вирусологии. - 1999. - № 3. - С. 124-126.
8. Ляшенко В.А., Александер С.К., Ковалева Л.Г., Лавров В.Ф., Юминова Н.В. Ранние проявления иммуномодулирующего действия коревой вакцины в эксперименте in vitro // Медицинская иммунология. - 2002. - Т. 4. - № 1. - С. 21-27.
9. Ляшенко В.А., Михайлова А.А., Александер С.К., Юминова Н.В., Фонина Л.А., Колышкин В.М. Влияние миелопептида-2 на результаты иммунизации иммунизации морских свинок ЖКВ // Вопр. вирусологии. - 2004. - № 2. - С. 18 - 20.
10. Максимов Н.Л., Букин Е.К., Агафонов А.П., Неверов А.А., Карпенко Л.И., Ильичов А.А., Игнатьев Г.М. ДНК-вакцинация кори в эксперименте: иммуногенность и безопасность // Вопр. вирусологии. - 2005. - № 1. - С. 4-9.
11. Петров Р.В., Михайлова А.А., Фонина Л.А., Степаненко Р.Н. Миелопептиды. - М.: «Наука», 2000. - 180 с.
12. Ярилин А.А. Основы иммунологии. - М.: «Медицина», 1999. - 600 с.
13. Bennett J.V., De Castro L.J., Valdespino-omez J.L., Valdespino-Gomez J.L., Garcia-arcia M.L., Islas-Romero R., Echaniz-Aviles G., Jimenez-Corona A., Sepulveda-Amor J. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responces than injected vaccines: randomized trials in Mexican schoolchildren // Bull. World Health Organ. - 2002. - Vol. 80, N 10. - Р. 806-812.
14. Bellanti J.L., Zeligs B.J., Mendez-Inocentio J., Garcia-Garcia M.L., Islas-Romero R., Omidvar B., Omidvar J., Kim G., de Castro J.F., Sepulveda A.J., Bellini V.J., Valdespino-Gomez J.L. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine // Vaccine. - 2004. - Vol. 22, Iss. 9-10. - P. 1214-1220.
15. Binnendiik R.S. van, Poelen M.C., van Amerongen G., de Vries P., Osterhaus A.D. Protective immunity in macaques vaccinated with live attenuated, recombinant and subunit measles vaccines in the presence of passively acquired antibodies // J. Infect. Dis. - 1997. - Vol. 175, N 3. - P. 524-532.
16. Bouche F.B., Steinmetz A., Yanagi Y., Muller C.P. Induction of broadly neutralizing antibodies against measles virus mutants using a polyepitope vaccine strategy // Vaccine. - 2005. - Vol. 23, Iss. 17-18. - P. 2074-2077.
17. Brinckman U.G., Bancamp B., Reich A., Ter Meulen V., Liebert U.G. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis // J. Gen. Virol. - 1991. - Vol. 72, N 10. - P. 2491-2500.
18. Cardoso A.I., Sixt N., Vallier A., Faiolle J., Buckland R., Wild T.F. Measles virus DNA vaccination: antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen // J. Virol. - 1998. - Vol. 72, N 3. - P. 2516-2518.
19. Chabot S., Brewer A., Lowell G., Plante M., Cyr S., Burt D.S., Ward B.J. A novel intranasal protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cellmediated immunity in mice // Vaccine. - 2005. - Vol. 23, Iss. 11. - P. 1374-1383.
20. Cutts F.I., Clements C.J., Bennett J.V. Alternative routes of measles immunization: a review // Biologicals. - 1997. - Vol. 25, N 3. - P. 323-338.
21. Сoates A.L., Tipples G., Leung K., Gray M., Louca F. How many infective viral particles are necessary for successful mass measles immunization by aerosol // Vaccine. - 2006. - Vol. 24, Iss. 10. - P. 1578 -1585.
22. Dilraj A., Cutts F.T., de Castro J.F., Wheeler J.G., Brown D., Roth C., Coovadia H.M., Bennett J.V. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomized trial // Lancet. - 2000. - Vol. 355, N 9206. - P. 798-803.
23. Drillen R., Spehner D., Kim A., Giraudon P., Buckland R., Wild F., Lecocq J.P. Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein // Proc. Natl. Acad. Sci. USA. - 1988. - Vol. 85, N 4. - P. 1252-1256.
24. Durbin A.P., Skiadopoulos M.H., McAuliffe J.M., Riggs J.M., Surman S.R., Collins P. L., Murphy B.R. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy // J. Virol. - 2000. - Vol. 4, N 15. - P. 6821-6831.
25. Ecunwe E.O. Immunization by inhalation of aerosolized measles vaccine // Ann. Trop. Ped. - 1990. - Vol. 10, N 2. - Р. 145-149.
26. Etchart N., Desmoulins P. O., Chemin K., Maliszewski C., Dubois B., Wild F., Kaiserlian D. Dendritic cells recruitment and in vivo priming of CD - CTL induced by a single topical or transepithelial immunization via the buccal mucosa with measles virus nucleoprotein // J. Immunol. - 2001. - Vol. 16, N 1. - P. 384-391.
27. Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., Bloom B.R. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector // J. Immunol. - 1999. - Vol. 162, N 3. - P. 1603-1610.
28. Fooks A.R., Jeevarajah D., Wames A., Wilkinson G.W., Clegg J.C. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene // Viral. Immunol. - 1996. - Vol. 9, N 2. - P. 65-71.
29. Freitag L.C., Clements J.D. Mucosal adjuvants // Vaccine. - 2005. - Vol. 23, Iss. 15. - P. 1804-1813.
30. Gundel I., Weidinger G., Ter Meulen V., Heesemann J., Russmann H., Niewiesk S. Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis // J. Gen. Virol. - 2003. - Vol. 4 (Pt 4). - P. 775-779.
31. Hathaway L.J., Partidos C.D., Vohra P., Steward M.W. Induction of systemic immune responses to measles virus synthetic peptides administered intranasally // Vaccine. - 1995. - Vol. 13, Iss. 16. - P. 1495-1500.
32. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P. J., Sherry B., Trinhiery G., Griffin D.E. Mechanism of suppression of cell-mediated immunity by measles virus // Science. - 1996. - Vol. 2 3. - P. 228-231.
33. El Kasmi K.C., Fillon S., Theisen D.M., Hartter H., Brons N.H., Muller C.P. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies // J. Gen. Virol. - 2000. - Vol. 1 (Pt 3). - P. 29-35.
34. Maggi T., Oggioni M.R., Medaglini D., Bianchi Bandinelli M.L., Soldateschi D., Wiesmuller K.H.,Muller C.P., Valensin P.E., Pozzi G. Expression of measles virus antigens in Streptococcus gordonii // New Microbiol. - 2000. - Vol. 23, N 2. - P. 119-128.
35. Martinez X., Brandt C., Saddallah F., Tougne C., Barrios C., Wild F., Dougan G., Lambert P. H., Siegrist C.A. DNA immunization circumvents deficient induction of T-helper type 1 and cytotoxic T-lymphocyte responses in neonates and during early life // Proc. Natl. Acad. Sci. USA. - 1997. - Vol. 94, N 16. - P. 26-31.
36. Niewiesk S., Ohnimus H., Schnorr JensJorg, Gotzelmann M., Schneider-Schaulies S., Jassoy C., Ter Meulen V. Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes // J. Gen. Virol. - 1999. - Vol. 80. - P. 2023-2029.
37. Obeid O.E., Stanley C.M., Steward M.W. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T-and B-cell epitopes from the fusion protein of measles virus // Virus Res. - 1996. - Vol. 42, N 1-2. - P. 173-180.
38. Ogra P. L., Fishot M., Gallagher M.R. Viral vaccination via the mucosal routes // Rev. Infect. Dis. - 1980. - Vol. 2, N 3. - P. 352-369.
39. Okada H., Sato T.A., Katayama A., Higuchi K., Shichijo K., Tsuchiva T., Takayama N., Takeuchi Y., Abe T., Okabe N., Tashiro M. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines // Arch. Virol. - 2001. - Vol. 146. - P. 859-874.
40. Ovsyannikova I.G., Johnson K.L., Naylor S., Poland G.A. Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1 0401 alleles induced by measles vaccine virus infection // J. Immunol. Methods. - 2000. - Vol. 246. - P. 1-12.
41. Ovsyannikova I.G., Johnson K.L., Naylor S., Muddiman D.C., Poland G.A. Naturally processed measles virus peptide eluted from class II HLADRB103 recognised by T-lymphocytes from human blood // Virology. - 2003. - Vol. 312. - P. 495-506.
42. Ovsyannikova I.G., Reid K.C., Jacobson R.M., Oberg A.L., Klee G.G., Poland J.A. Cytokine production patterns and antibody response to measles vaccine // Vaccine. - 2003 - Vol. 21, Iss. 25-26. - P. 3946-3953.
43. Ovsyannikova I.G., Johnson K.L., Muddiman D.C., Viercant R.A., Poland J.A. Identification and characterization of Novel Naturally Processed Measles Virus Class 11 HLA-DRB1 Peptides // J. Virol. - 2004. - Vol., N 1. - P. 42-51.
44. Partidos C.D., Pizza M., Rappuoli R., Steward M.W. The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide // Immunology. - 1996. - Vol. 89, N 4. - P. 483-487.
45. Pasetti M.F., Barry E.M., Losonsky G., Singh M., Medina-Moreno S.M., Polo J.M., Ulmer J., Robinson H., Sztein M.B. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats // J. Virol. - 2003. - Vol. 77, N 9. - P. 5209-5217.
46. Polack F.P., Lee S.H., Permar S., Manyara E., Nousari H.G., Jeng Y., Mustafa F., Valsamakis A., Adams R.J., Robinson H.L., Griffin D.E. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles // Nat. Med. - 2000. - Vol. 6, N 7. - P. 776-781.
47. Poland J.A., Ovsyannikova I.G., Johson K.L., Naylor S. The role of mass spectrometry in vaccine development // Vaccine. - 2001 - Vol. 19. - P. 2692-2700.
48. Poland J.A., Ovsyannicova I.G., Jacobson R.M., Viercant R.A., Jacobsen S.J., Pancratz V.S., Schade D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization // Vaccine. - 2002. - Vol. 20. - P. 430-438.
49. Putz M.M., Ammerlaan W., Schneider F., Jung G., Muller C.P. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens // Vaccine. - 2004 - Vol. 22, Iss. 31-32. - P. 4173-4182.
50. Sabin A.B., Flores A.A., de Castro J.F., Sever J.L., Madden D.L., Shekarchi I., Albrecht P. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. 1. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines // JAMA - 1983. - Vol. 249, N 19. - P. 2651-2662.
51. Sauver J.L., Schade D.J., Viercant R.A., Jacobson R.M., Jacobsen S.J., Ovsiannicova I.G., Poland G.A. Association between measles antibody level and the protein structure of class II human leucocyte antigens // Hum. Immunol. - 2003. - Vol. 64. - P. 696-707.
52. Schlereth B., Germann P. G., ter Meulen V., Niewiesk S. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection // J. Gen. Virol. - 2000. - Vol. 1 (Pt 5). - P. 1321-1325.
53. Schlender J., Schnorr J.J., Spielhoffer P., Cathomen T., Cattaneo R., Billeter M.A., Ter Meulen V., Schneider-Schaulies S. Interaction of measles virus glycoproteins with the surface of uninfected peripheral peripheral blood lymphocytes induces immunosuppression in vitro // Proc. Natl. Acad. Sci. USA - 1966. - Vol. 93. - P. 13194-13199.
54. Sharpe S., Fooks A., Lee J., Hayes K., Clegg C., Cranage M. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses // Virology. - 2002. - Vol. 293, N 2. - P. 210-216.
55. Song M.K., Vindurampulle C.J., Capozzo A.V., Ulmner J., Polo J.M., Pasetti M.F., Barry E.M., Levine V.V. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins // J. Virol. - 2005. - Vol. 9, N 15. - P. 9854-9861.
56. Stittelaar K.J., Vos H.W., van Amerongen G., Kersten G.F., Osterhaus A.D., de Swart R.L.Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates // Vaccine. - 2002. - Vol. 21, Iss. 3-4. - P. 155-157.
57. Torres C.A., Yang K., Mustafa F., Robinson H.L. DNA immunization: effect of secretion of DNAexpressed hemagglutinins on antibody responses // Vaccine. - 1999. - Vol. 1, Iss. 9-10. - P. 805-814.
58. Wong-Chew R.M., Islas-Romero R., Garcia-arcia Mde L, Beeler J.A., Audet S., Santos-Presiado I.L., Gans H., Lew-Yasukawa L, Maldonado Y.A., Arvin A.M., Valdespino-Gomez J.L. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children // Vaccine. - 2006. - Vol. 24, Iss. 5. - P. 683-690.
59. Weidinger G., Ohlmann M., Schlereth B., Sutter G., Niewiesk S. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model // Vaccine. - 2001 - Vol. 19, Iss. 20-22. - P. P. 2764-2768.
60. Wild T.F., Bemard A., Spehner D., Drillien R. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice // J. Gen. Virol. - 1992. - Vol. 3 (Pt 2). - P. 359-36.
61. Yang K., Mustafa F., Valsamakis A., Santoro J.C., Griffin D.E., Robinson H.L. Early studies on DNAbased immunizations for measles virus // Vaccine. - 1997. - Vol. 15, Iss. 8. - P. - 888 -891.
62. Zhu Y.D., Fennelly G., Miller C., Tarara R., Saxe I., Bloom B., McChesney M. Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia // J. Infect. Dis. - 1997. - Vol. 176, N 6. - P. 1445-1453.
63. Zhu Y., Rota P., Wyatt L., Tamin A., Rosenblatt S., Lerche N., Moss B., Bellini W., McChesney M. Evaluation of recombinant vaccinia virus - measles vaccines in infant rhesus macaques with preexisting measles antibody // Virology. - 2000. - Vol. 276, N 1. - Р. 202-213.
Рецензия
Для цитирования:
Ляшенко В.А. ЭКСПЕРИМЕНТАЛЬНЫЕ КОРЕВЫЕ ВАКЦИНЫ КАК ИНСТРУМЕНТ ИССЛЕДОВАНИЯ ВАКЦИНАЛЬНОГО ПРОЦЕССА. Медицинская иммунология. 2007;9(1):7-14. https://doi.org/10.15789/1563-0625-2007-1-7-14
For citation:
Liashenko V.A. EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS. Medical Immunology (Russia). 2007;9(1):7-14. (In Russ.) https://doi.org/10.15789/1563-0625-2007-1-7-14
Просмотров: 947
Послать статью по эл. почте 